ADMA BIOLOGICS, INC. Long-Term Debt
ADMA BIOLOGICS, INC. (ADMA) had Long-Term Debt of $192.84 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-05
- 2026-06-30: Long-term Debt, Excluding Current Maturities $192.84M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $193.58M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $69.33M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $70.08M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-06-30 | $192.84M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $193.58M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $69.33M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $70.08M 10-Q · filed 2025-11-05 |
| 2024-12-31 | $72.34M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |